APYX Quote, Financials, Valuation and Earnings

Nephros, Inc. has a net margin of -15.18% compared to Apyx Medical Corp.'s net margin of 7.07%. Apyx Medical Corp.'s return on equity of -146.08% beat Nephros, Inc.'s return on equity of 16.22%.

Apyx Medical Corp. has a consensus price target of $6.00, signalling upside risk potential of 66.67%. On the other hand Nephros, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 24.28%. Given that Apyx Medical Corp. has higher upside potential than Nephros, Inc., analysts believe Apyx Medical Corp. is more attractive than Nephros, Inc..

Apyx Medical Corp. has a beta of 1.486, which suggesting that the stock is 48.62% more volatile than S&P 500. In comparison Nephros, Inc. has a beta of 1.483, suggesting its more volatile than the S&P 500 by 48.288%.

Apyx Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nephros, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Apyx Medical Corp. pays -- of its earnings as a dividend. Nephros, Inc. pays out -- of its earnings as a dividend.

Apyx Medical Corp. quarterly revenues are $12.9M, which are larger than Nephros, Inc. quarterly revenues of $4.8M. Apyx Medical Corp.'s net income of -$2M is lower than Nephros, Inc.'s net income of $337K. Notably, Apyx Medical Corp.'s price-to-earnings ratio is -- while Nephros, Inc.'s PE ratio is 37.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Apyx Medical Corp. is 3.06x versus 3.14x for Nephros, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Owlet, Inc. has a net margin of -15.18% compared to Apyx Medical Corp.'s net margin of 12.58%. Apyx Medical Corp.'s return on equity of -146.08% beat Owlet, Inc.'s return on equity of --.

Apyx Medical Corp. has a consensus price target of $6.00, signalling upside risk potential of 66.67%. On the other hand Owlet, Inc. has an analysts' consensus of $14.88 which suggests that it could fall by -2.59%. Given that Apyx Medical Corp. has higher upside potential than Owlet, Inc., analysts believe Apyx Medical Corp. is more attractive than Owlet, Inc..

Apyx Medical Corp. has a beta of 1.486, which suggesting that the stock is 48.62% more volatile than S&P 500. In comparison Owlet, Inc. has a beta of 1.734, suggesting its more volatile than the S&P 500 by 73.364%.

Apyx Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Owlet, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Apyx Medical Corp. pays -- of its earnings as a dividend. Owlet, Inc. pays out -- of its earnings as a dividend.

Apyx Medical Corp. quarterly revenues are $12.9M, which are smaller than Owlet, Inc. quarterly revenues of $32M. Apyx Medical Corp.'s net income of -$2M is lower than Owlet, Inc.'s net income of $4M. Notably, Apyx Medical Corp.'s price-to-earnings ratio is -- while Owlet, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Apyx Medical Corp. is 3.06x versus 2.56x for Owlet, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -15.18% compared to Apyx Medical Corp.'s net margin of -862.39%. Apyx Medical Corp.'s return on equity of -146.08% beat VolitionRX Ltd.'s return on equity of --.

Apyx Medical Corp. has a consensus price target of $6.00, signalling upside risk potential of 66.67%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 773.02%. Given that VolitionRX Ltd. has higher upside potential than Apyx Medical Corp., analysts believe VolitionRX Ltd. is more attractive than Apyx Medical Corp..

Apyx Medical Corp. has a beta of 1.486, which suggesting that the stock is 48.62% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Apyx Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Apyx Medical Corp. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Apyx Medical Corp. quarterly revenues are $12.9M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Apyx Medical Corp.'s net income of -$2M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Apyx Medical Corp.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Apyx Medical Corp. is 3.06x versus 17.27x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -15.18% compared to Apyx Medical Corp.'s net margin of 3.93%. Apyx Medical Corp.'s return on equity of -146.08% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Apyx Medical Corp. has a consensus price target of $6.00, signalling upside risk potential of 66.67%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.8%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Apyx Medical Corp., analysts believe Xtant Medical Holdings, Inc. is more attractive than Apyx Medical Corp..

Apyx Medical Corp. has a beta of 1.486, which suggesting that the stock is 48.62% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Apyx Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Apyx Medical Corp. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Apyx Medical Corp. quarterly revenues are $12.9M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Apyx Medical Corp.'s net income of -$2M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Apyx Medical Corp.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Apyx Medical Corp. is 3.06x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.